Riitta Niittyvuopio

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

Alexandros Spyridonidis, Myriam Labopin, Bipin N. Savani et al. · Bone Marrow Transplantation · 2020 · 203 citations · Full text

Medicine, Oncology, Stem Cell Transplantation +14

Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years

Ali Bazarbachi, Christoph Schmid, Myriam Labopin et al. · Clinical Cancer Research · 2020 · 81 citations · Full text

Medicine, Hematology, Hematologic Oncology +14

Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

Jiří Pavlů, Myriam Labopin, Riitta Niittyvuopio et al. · Journal of Hematology & Oncology · 2019 · 78 citations · Full text

Medicine, Hematology, Oncology +15

Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors

Éolia Brissot, Myriam Labopin, Jan J. Cornelissen et al. · Journal of Hematology & Oncology · 2020 · 68 citations · Full text

Life Sciences, Hematology, Immunology +16

Good responses but high TRM in adult patients after MSC therapy for GvHD

Urpu Salmenniemi, Maija Itälä‐Remes, Johanna Nystedt et al. · Bone Marrow Transplantation · 2016 · 64 citations

Medicine, Radiology, Cell Therapy +2